APA

Bailly A., Perrin A., Bou Malhab L. J., Pion E., Larance M., Nagala M., Smith P., O'Donohue M., Gleizes P., Zomerdijk J., Lamond A. I. & Xirodimas D. P. (20160620). The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway. : Oncogene.

Chicago

Bailly A, Perrin A, Bou Malhab L J, Pion E, Larance M, Nagala M, Smith P, O'Donohue M-F, Gleizes P-E, Zomerdijk J, Lamond A I and Xirodimas D P. 20160620. The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway. : Oncogene.

Harvard

Bailly A., Perrin A., Bou Malhab L. J., Pion E., Larance M., Nagala M., Smith P., O'Donohue M., Gleizes P., Zomerdijk J., Lamond A. I. and Xirodimas D. P. (20160620). The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway. : Oncogene.

MLA

Bailly A, Perrin A, Bou Malhab L J, Pion E, Larance M, Nagala M, Smith P, O'Donohue M-F, Gleizes P-E, Zomerdijk J, Lamond A I and Xirodimas D P. The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway. : Oncogene. 20160620.